Literature DB >> 3488088

Increased levels of osteocalcin (serum bone Gla-protein) in rheumatoid arthritis.

G Gevers, P Devos, M De Roo, J Dequeker.   

Abstract

Serum osteocalcin was measured by radio-immunoassay in 56 patients with rheumatoid arthritis (RA), and in 50 controls. Mean serum osteocalcin levels were significantly higher in patients with RA. There was a positive correlation between osteocalcin and fasting mucopolysaccharide/creatinine ratio in both sexes, and between osteocalcin and fasting hydroxyproline/creatinine ratio in women. Serum alkaline phosphatase activity, a less specific marker for bone formation, was also increased in RA, and there was a positive correlation with osteocalcin in both sexes. These data suggest that overall bone turnover is increased in RA and that serum osteocalcin may provide additional information for the evaluation of bone metabolism in this disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488088     DOI: 10.1093/rheumatology/25.3.260

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  21 in total

1.  Intranasal calcitonin for the prevention of bone erosion and bone loss in rheumatoid arthritis.

Authors:  A Sileghem; P Geusens; J Dequeker
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

2.  Sex- and age-related changes in bone and serum osteocalcin.

Authors:  D Vanderschueren; G Gevers; G Raymaekers; P Devos; J Dequeker
Journal:  Calcif Tissue Int       Date:  1990-03       Impact factor: 4.333

Review 3.  Osteoporosis and arthritis.

Authors:  J Dequeker; P Geusens
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

Review 4.  Bone metabolism in patients with rheumatoid arthritis.

Authors:  J W Bijlsma
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

5.  Abnormal osteocalcin binding in rheumatoid arthritis.

Authors:  A Fairney; K V Patel; N P Hollings; M H Seifert
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

6.  Serum osteocalcin concentrations in patients with rheumatoid arthritis.

Authors:  P Pietschmann; K P Machold; W Wolosczuk; J S Smolen
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

7.  Osteocalcin and bone mineral content in rheumatoid arthritis.

Authors:  A Peretz; J P Praet; S Rozenberg; D Bosson; J P Famaey; P Bourdoux
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

8.  Serum osteocalcin (bone Gla-protein) following corticosteroid therapy in postmenopausal women with rheumatoid arthritis. Comparison of the effect of prednisone and deflazacort.

Authors:  C Montecucco; F Baldi; A Fortina; G Tomassini; R Caporali; E L Cherie-Ligniere; P Fratino
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

9.  Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis.

Authors:  H Kröger; J Risteli; L Risteli; I Penttilä; E Alhava
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

10.  Short-term course of 1,25(OH)2D3 stimulates osteoblasts but not osteoclasts in osteoporosis and osteoarthritis.

Authors:  P Geusens; D Vanderschueren; A Verstraeten; J Dequeker; P Devos; R Bouillon
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.